Maronde R F, Barr J, Vlachakis N D, Spencer C A, Chan L
Clin Pharmacol Ther. 1984 Oct;36(4):431-5. doi: 10.1038/clpt.1984.200.
To compare the effect of amiloride with that of oral potassium chloride (KCl) in hypokalemia, metabolic balance studies were carried out in hospitalized subjects with mild hypertension without edema who developed negative potassium balance after 4 days on hydrochlorothiazide (HCTZ). Subjects' diets contained measured amounts of sodium and potassium. While HCTZ treatment continued, oral preparations of either KCl solution or amiloride was added for 5 additional days. Potassium balance in the KCl-treated group further decreased by -44.9 +/- 32.3 mEq K+, while subjects on amiloride went into positive balance that averaged +51.7 +/- 24.1 mEq K+. Hypokalemia after HCTZ did not respond to KCl, while K+ levels rose from 3.32 +/- 0.22 to 3.67 +/- 0.26 mEq/l after amiloride.
为比较阿米洛利与口服氯化钾(KCl)对低钾血症的疗效,对轻度高血压且无水肿的住院患者进行了代谢平衡研究,这些患者在服用氢氯噻嗪(HCTZ)4天后出现钾负平衡。受试者的饮食含有定量的钠和钾。在继续使用HCTZ治疗的同时,额外添加KCl溶液或阿米洛利口服制剂,持续5天。KCl治疗组的钾平衡进一步下降了-44.9±32.3 mEq K+,而服用阿米洛利的受试者则进入正平衡,平均为+51.7±24.1 mEq K+。HCTZ后的低钾血症对KCl无反应,而服用阿米洛利后钾水平从3.32±0.22 mEq/L升至3.67±0.26 mEq/L。